Celularity (CELU) Asset Utilization Ratio (2021 - 2025)
Celularity (CELU) posted quarterly Asset Utilization Ratio of 0.46 for Q4 2025, up 64.79% year-over-year from 0.28 in Q4 2024, and up 134.91% quarter-over-quarter from 0.2 in Q3 2025.
Celularity (CELU) Asset Utilization Ratio (2021 - 2025) Analysis & Trends
Celularity (CELU) has reported Asset Utilization Ratio for 5 consecutive years, with 0.46 the latest figure, recorded in Q4 2025.
- In Q4 2025, Asset Utilization Ratio rose 64.79% year-over-year to 0.46; the TTM figure through Dec 2025 stood at 0.46 (up 64.79% YoY), while the FY2025 annual figure was 0.4, up 1.81% from the prior year.
- Asset Utilization Ratio improved to 0.46 in Q4 2025 per CELU's latest filing, from 0.2 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.46 in Q4 2025 and bottomed at 0.04 in Q1 2023.
- Historically, Asset Utilization Ratio has averaged 0.16 across 5 years, with a median of 0.07 in 2023.
- Annual changes were most pronounced in 2024 — Asset Utilization Ratio jumped 514.75% — and 2025, when it slumped 45.9%.
- Celularity's Asset Utilization Ratio stood at 0.05 in 2021, then retreated by 13.31% to 0.04 in 2022, then jumped by 252.67% to 0.15 in 2023, then jumped by 85.93% to 0.28 in 2024, then soared by 64.79% to 0.46 in 2025.
- Business Quant data shows CELU's Asset Utilization Ratio at 0.46 in Q4 2025, 0.2 in Q3 2025, and 0.22 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.13 |
| 10 | Celularity | 20.99 Mn | 14.82 Mn | -3.27 Mn | 0.46 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.46 |
| Sep 30, 2025 | 0.20 |
| Jun 30, 2025 | 0.22 |
| Mar 31, 2025 | 0.26 |
| Dec 31, 2024 | 0.28 |
| Sep 30, 2024 | 0.36 |
| Jun 30, 2024 | 0.31 |
| Mar 31, 2024 | 0.23 |
| Dec 31, 2023 | 0.15 |
| Sep 30, 2023 | 0.07 |
| Jun 30, 2023 | 0.05 |
| Mar 31, 2023 | 0.04 |
| Dec 31, 2022 | 0.04 |
| Sep 30, 2022 | 0.04 |
| Jun 30, 2022 | 0.06 |
| Mar 31, 2022 | 0.06 |
| Dec 31, 2021 | 0.05 |
| Sep 30, 2021 | 0.07 |
| Jun 30, 2021 | 0.06 |